Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and meta‐analysis of …
S Dang, S Zhang, J Zhao, X Li, W Li - Cancer Medicine, 2023 - Wiley Online Library
Abstract Background Immune checkpoint inhibitors (ICIs) showed antitumor activity for
recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). However …
recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). However …
Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis of …
S Dang, S Zhang, J Zhao, X Li, W Li - Cancer Medicine, 2023 - europepmc.org
Background Immune checkpoint inhibitors (ICIs) showed antitumor activity for recurrent or
metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the results …
metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the results …
[HTML][HTML] Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta …
S Dang, S Zhang, J Zhao, X Li, W Li - Cancer Medicine, 2023 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) showed antitumor activity for recurrent or
metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the results …
metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the results …
Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta‐analysis of …
S Dang, S Zhang, J Zhao, X Li, W Li - Cancer Medicine, 2023 - search.ebscohost.com
Abstract Background: Immune checkpoint inhibitors (ICIs) showed antitumor activity for
recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). However …
recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). However …
Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis of …
S Dang, S Zhang, J Zhao, X Li, W Li - Cancer Medicine, 2023 - search.proquest.com
Background Immune checkpoint inhibitors (ICIs) showed antitumor activity for recurrent or
metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the results …
metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the results …
Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis of …
S Dang, S Zhang, J Zhao, X Li, W Li - Cancer medicine - pubmed.ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) showed antitumor activity for recurrent or
metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the results …
metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the results …
Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis of …
S Dang, S Zhang, J Zhao, X Li, W Li - Cancer Medicine, 2023 - europepmc.org
Background Immune checkpoint inhibitors (ICIs) showed antitumor activity for recurrent or
metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the results …
metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the results …